We titrate deliberately to minimize side effects, which means the first weeks often feel like the medication is barely doing anything on the craving front
Over time, this pattern can contribute to fatigue, persistent inflammation, delayed tissue healing, chronic pain persistence, and increased vulnerability to long-term metabolic and immune dysfunction
Stelara (ustekinumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $10.36 billion Why it sold so well: J&Js immunology blockbuster Stelara generated approximately $10.36 billion in global sales in 2024, a 4.6% decline from the previous year
Long-Term Weight Loss & Maintenance with Semaglutide in Obesity (2022 Review of STEP Trials) consolidates findings across multiple STEP trials (1, 3, 4, 8), showing 14.917.4% mean weight loss over 68 weeks, improved cardiometabolic markers, and better quality-of-life outcomes
Apply generously 1520 minutes before sun exposure